Cabka (CABKA) Q3 2025 TU earnings summary

Executive summary

• Q3 sales remained stable at €42.1 million, nearly matching Q3 2024's €42.4 million.

• Year-to-date sales reached €132 million, slightly down from €135 million in the same period last year.

• Operational efficiency and disciplined pricing led to a slight increase in EBITDA margin over sales compared to last year.

• Focus remains on positive cash flow, cost control, and business segment diversification.

Financial highlights

• Q3 sales: €42.1 million, broadly stable year-over-year.

• Year-to-date sales: €132 million, down from €135 million year-over-year.

• EBITDA margin over sales slightly improved compared to last year.

Outlook and guidance

• Full-year 2025 sales and EBITDA expected to be broadly in line with 2024.

• Market conditions remain challenging due to persistent volatility and trade disruptions.

• Updated Business Strategy 2030 and growth plans to be shared at the Virtual Capital Markets Update on 19 November 2025.